Understanding the connection between fructose-containing beverages and fatty liver disease empowers people to make informed choices. By reducing sugary drink intake and adopting healthier habits, it is possible to protect the liver and improve overall health.

Zepbound is a different type of GLP-1 used to treat weight problems. It is an advancement over the Wegovy-Ozempic class in that it is a dual receptor acting agent. More so, it is covered under many Medicare Prescription plans in patients that suffer from sleep apnea (obstructive sleep apnea) after documentation with sleep study.